Triple Therapy Shows Edge in Lung Cancer Lacking Targetable Mutations
A new network meta-analysis of five trials involving 2,452 patients finds that triple therapy combining immunotherapy, antiangiogenic antibodies, and chemotherapy ...
A new network meta-analysis of five trials involving 2,452 patients finds that triple therapy combining immunotherapy, antiangiogenic antibodies, and chemotherapy ...
The Phase III LONESTAR trial found that adding radiation or surgery after nivolumab plus ipilimumab did not improve survival in ...
A new review maps how the CD73-adenosine axis drives immune suppression in non-small cell lung cancer and how blocking it ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine